Article in Microbiology resource announcements, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
Antonio Broncano-LavadoDepartment of Clinical Microbiology, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS FJD), Madrid, Spain.
Françoise Roquet-BanèresCentre National de la Recherche Scientifique UMR 9004, Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier, Montpellier, France.ORCID 0000-0003-2636-3734
Laurent KremerCentre National de la Recherche Scientifique UMR 9004, Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier, Montpellier, France.ORCID 0000-0002-6604-4458
Daniel A RussellDepartment of Biological Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.ORCID 0000-0001-6894-2748
Deborah Jacobs-SeraDepartment of Biological Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.ORCID 0000-0001-7838-3257
Thomas G ReidyDepartment of Biological Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.ORCID 0009-0008-4340-612X
John J Aguilera-CorreaDepartment of Clinical Microbiology, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS FJD), Madrid, Spain.
Jaime EstebanDepartment of Clinical Microbiology, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS FJD), Madrid, Spain.
Graham F HatfullDepartment of Biological Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.ORCID 0000-0002-6705-6821
Meritxell García-QuintanillaDepartment of Clinical Microbiology, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS FJD), Madrid, Spain.
Funding
Bacteriophage diversity, dynamics, function, and exploitationR35GM131729 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Graham F. Hatfull · 2019 to 2026
$3.6M
Image-Seq: A high-density microfluidic trap array for single cell transcriptome analysis coupled with image based phenotypingR21GM131279 · NIGMS · DUKE UNIVERSITY · PI TATA, PURUSHOTHAMA RAO · 2018 to 2019
$432k
Association Vaincre la MucoviscidoseCentro de Investigación Biotecnológica en Red de Enfermedades Infecciosas (CIBERINFEC)Howard Hughes Medical Institute GT12053NIGMS NIH HHS R21 GM131279NIGMS NIH HHS R35 GM131729NIH HHS GM131279
6 · The paper itself
Abstract
Mycobacteriophage P3MA is a newly isolated bacteriophage recovered from the Manzanares River in Madrid, Spain, using
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.